Suzhou Fushilai Pharmaceutical Co. Ltd. Total Liabilities

Latest as of June 2025: CN¥211.52 Million CNY ≈ $30.95 Million USD

Suzhou Fushilai Pharmaceutical Co. Ltd. total liabilities. Based on the latest financial reports, Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has total liabilities worth CN¥211.52 Million CNY (≈ $30.95 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 301258 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)

Total liabilities of Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024. This chart illustrates how Suzhou Fushilai Pharmaceutical Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data.

Suzhou Fushilai Pharmaceutical Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of Suzhou Fushilai Pharmaceutical Co. Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Taeyoung Engineering & Construction Co.,Ltd. KO:009410	Korea	₩3.15 Trillion
Bharat Bijlee Limited NSE:BBL	India	Rs-20.29 Billion
Eikon Therapeutics, Inc. Common Stock NASDAQ:EIKN	USA	$313.07 Million
Eaton Vance Senior Floating Rate Closed Fund NYSE:EFR	USA	$104.27 Million
NHN KCP Corp KQ:060250	Korea	₩359.08 Billion
Agenus Inc NASDAQ:AGEN	USA	$378.54 Million
Chengdu Rainbow Appliance Gr SHE:003023	China	CN¥590.66 Million
Isabella Bank Corporation NASDAQ:ISBA	USA	$1.97 Billion

Liability Composition Analysis (2019–2024)

This chart breaks down Suzhou Fushilai Pharmaceutical Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Suzhou Fushilai Pharmaceutical Co. Ltd. assets under control.

Liquidity & Leverage Metrics

Suzhou Fushilai Pharmaceutical Co. Ltd. Total Liabilities Ratios Explained

Suzhou Fushilai Pharmaceutical Co. Ltd. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	10.37	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Suzhou Fushilai Pharmaceutical Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)

The table below shows the annual total liabilities of Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥200.84 Million ≈ $29.39 Million	+17.83%
2023-12-31	CN¥170.45 Million ≈ $24.94 Million	-19.50%
2022-12-31	CN¥211.75 Million ≈ $30.99 Million	-6.91%
2021-12-31	CN¥227.47 Million ≈ $33.29 Million	+37.35%
2020-12-31	CN¥165.61 Million ≈ $24.23 Million	-2.28%
2019-12-31	CN¥169.48 Million ≈ $24.80 Million	--

About Suzhou Fushilai Pharmaceutical Co. Ltd.

SHE:301258 China Biotechnology

Market Cap

$300.48 Million

CN¥2.05 Billion CNY

Market Cap Rank

#14497 Global

#4275 in China

Share Price

CN¥22.40

Change (1 day)

+0.09%

52-Week Range

CN¥21.91 - CN¥37.35

All Time High

CN¥63.49